While CHIP is often detected incidentally, its strong associations with atherosclerosis, coronary artery disease, stroke, and possibly neurodegeneration suggest that it could serve as both a biomarker for risk stratification and a potential therapeutic target. This evidence concerns the gene STUB1 and Stroke.